BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38000024)

  • 1. DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity.
    Kureshi R; Bello E; Kureshi CTS; Walsh MJ; Lippert V; Hoffman MT; Dougan M; Longmire T; Wichroski M; Dougan SK
    Sci Adv; 2023 Nov; 9(47):eadk1853. PubMed ID: 38000024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
    Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
    Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8
    Clancy-Thompson E; Devlin CA; Tyler PM; Servos MM; Ali LR; Ventre KS; Bhuiyan MA; Bruck PT; Birnbaum ME; Dougan SK
    Cancer Immunol Res; 2018 Dec; 6(12):1524-1536. PubMed ID: 30352798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
    Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
    Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling.
    Baldanzi G; Pighini A; Bettio V; Rainero E; Traini S; Chianale F; Porporato PE; Filigheddu N; Mesturini R; Song S; Schweighoffer T; Patrussi L; Baldari CT; Zhong XP; van Blitterswijk WJ; Sinigaglia F; Nichols KE; Rubio I; Parolini O; Graziani A
    J Immunol; 2011 Dec; 187(11):5941-51. PubMed ID: 22048771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
    Andrada E; Liébana R; Merida I
    EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graded diacylglycerol kinases α and ζ activities ensure mucosal-associated invariant T-cell development in mice.
    Pan Y; Deng W; Xie J; Zhang S; Wan ECK; Li L; Tao H; Hu Z; Chen Y; Ma L; Gao J; Zhong XP
    Eur J Immunol; 2020 Feb; 50(2):192-204. PubMed ID: 31710099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol kinases in cancer.
    Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
    Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse.
    Gharbi SI; Rincón E; Avila-Flores A; Torres-Ayuso P; Almena M; Cobos MA; Albar JP; Mérida I
    Mol Biol Cell; 2011 Nov; 22(22):4406-14. PubMed ID: 21937721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.
    Dougan SK; Dougan M; Kim J; Turner JA; Ogata S; Cho HI; Jaenisch R; Celis E; Ploegh HL
    Cancer Immunol Res; 2013 Aug; 1(2):99-111. PubMed ID: 24459675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice.
    Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP
    Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity.
    Wichroski M; Benci J; Liu SQ; Chupak L; Fang J; Cao C; Wang C; Onorato J; Qiu H; Shan Y; Banas D; Powles R; Locke G; Witt A; Stromko C; Qi H; Zheng X; Martin S; Ding M; Gentles R; Meanwell N; Velaparthi U; Olson R; Wee S; Tenney D; Parker CG; Cravatt BF; Lawrence M; Borzilleri R; Lees E
    Sci Transl Med; 2023 Oct; 15(719):eadh1892. PubMed ID: 37878674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DGKζ exerts greater control than DGKα over CD8
    Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ
    Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
    Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
    Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.
    Arumugam V; Bluemn T; Wesley E; Schmidt AM; Kambayashi T; Malarkannan S; Riese MJ
    J Leukoc Biol; 2015 Nov; 98(5):703-12. PubMed ID: 26153417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation.
    Yang J; Zhang P; Krishna S; Wang J; Lin X; Huang H; Xie D; Gorentla B; Huang R; Gao J; Li QJ; Zhong XP
    Oncotarget; 2016 Jun; 7(23):33744-64. PubMed ID: 27014906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction.
    Velnati S; Centonze S; Rossino G; Purghè B; Antona A; Racca L; Mula S; Ruffo E; Malacarne V; Malerba M; Manfredi M; Graziani A; Baldanzi G
    Front Immunol; 2023; 14():1043603. PubMed ID: 37138877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redundant and specialized roles for diacylglycerol kinases α and ζ in the control of T cell functions.
    Mérida I; Andrada E; Gharbi SI; Ávila-Flores A
    Sci Signal; 2015 Apr; 8(374):re6. PubMed ID: 25921290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases.
    Shin J; O'Brien TF; Grayson JM; Zhong XP
    J Immunol; 2012 Mar; 188(5):2111-7. PubMed ID: 22271650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta.
    Guo R; Wan CK; Carpenter JH; Mousallem T; Boustany RM; Kuan CT; Burks AW; Zhong XP
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11909-14. PubMed ID: 18689679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.